Sibling recurrence risk in Dupuytren's disease.

Sibling recurrence risk in Dupuytren's disease.

Dupuytren's disease is a complex condition, with both genetic and environmental factors contributing to its aetiology. We aimed to quantify the extent to which genetic factors predispose to the disease, through the calculation of sibling recurrence risk (ls), and to calculate the proportion of...

Descrizione completa

Dettagli Bibliografici
Autori principali:	Capstick, R, Bragg, T, Giele, H, Furniss, D
Natura:	Journal article
Lingua:	English
Pubblicazione:	2013

Documenti analoghi

A weighted genetic risk score predicts surgical recurrence independent of high-risk clinical features in Dupuytren’s disease
di: Riesmeijer, S, et al.
Pubblicazione: (2019)

Wnt signaling and Dupuytren's disease.
di: Dolmans, G, et al.
Pubblicazione: (2011)

Genome-wide association scan of Dupuytren's disease.
di: Furniss, D, et al.
Pubblicazione: (2011)

Is Dupuytren’s disease really a “disease of the Vikings”?
di: Ng, M, et al.
Pubblicazione: (2019)

Recurrence of Dupuytren's contracture: A consensus-based definition
di: Kan, HJ, et al.
Pubblicazione: (2017)

Treatment for Dupuytren's disease
di: Nanchahal, J, et al.
Pubblicazione: (2013)

Surgery for Dupuytren's contracture of the fingers.
di: Rodrigues, J, et al.
Pubblicazione: (2015)

Sibling recurrence risk and its relevance to the genetics of ankylosing spondylitis
di: Carter, N, et al.
Pubblicazione: (1998)

The role of manual occupation in the aetiology of Dupuytren's disease in men in England and Wales.
di: Khan, A, et al.
Pubblicazione: (2004)

The relationship between body mass index and the risk of development of Dupuytren's disease: a Mendelian randomization study.
di: Majeed, M, et al.
Pubblicazione: (2020)

Dupuytren disease: prevalence, incidence, and lifetime risk of surgical intervention. A population-based cohort analysis
di: Broekstra, DC, et al.
Pubblicazione: (2022)

The molecular genetics of dupuytren disease
di: Ng, M
Pubblicazione: (2018)

Integrative analysis of Dupuytren's disease identifies novel risk locus and reveals a shared genetic etiology with BMI
di: Major, M, et al.
Pubblicazione: (2019)

Commentary on Larson et al. Genetic and environmental influences in Dupuytren's disease: A study of 30,330 Danish twin pairs
di: Furniss, D
Pubblicazione: (2015)

Twin concordance and sibling recurrence rates in multiple sclerosis.
di: Willer, C, et al.
Pubblicazione: (2003)

Recent advances in the understanding of Dupuytren's disease
di: Nanchahal, J, et al.
Pubblicazione: (2019)

Tonometry as an outcome measure for the treatment of Dupuytren’s disease.
di: Ball, C, et al.
Pubblicazione: (2015)

Tonometry as an outcome measure for the treatment of Dupuytren’s disease.
di: Ball, C, et al.
Pubblicazione: (2016)

Heterotopic ossification in Dupuytren's disease: clinical and histological significance.
di: Sadideen, H, et al.
Pubblicazione: (2011)

Single cell analysis of the fibrotic landscape in Dupuytren's disease
di: Layton, T
Pubblicazione: (2019)

Predicting the outcome of surgery for the proximal interphalangeal joint in Dupuytren's disease.
di: Misra, A, et al.
Pubblicazione: (2007)

Systematic review of non-surgical treatments for early Dupuytren’s disease
di: Ball, C, et al.
Pubblicazione: (2016)

Sibling risks for multiple sclerosis
di: Sadovnick, A, et al.
Pubblicazione: (1996)

A common SNP risk variant MT1-MMP causative for Dupuytren’s Disease has a specific defect in collagenolytic activity
di: Itoh, Y, et al.
Pubblicazione: (2021)

A genome-wide association study of Dupuytren's disease reveals 17 additional variants implicated in fibrosis
di: Ng, M, et al.
Pubblicazione: (2017)

Dupuytren's disease: a localised and accessible human fibrotic disorder
di: Layton, TB, et al.
Pubblicazione: (2022)

Treatments for early-stage Dupuytren’s disease: an evidence-based approach
di: Nanchahal, J, et al.
Pubblicazione: (2023)

Dupuytren’s disease predicts increased all-cause and cancer-specific mortality: analysis of a large cohort from the UK Clinical Practice Research Datalink
di: Kuo, R, et al.
Pubblicazione: (2019)

Molecular genetics of Dupuytren’s contracture
di: Aissvarya, Shankar, et al.
Pubblicazione: (2024)

A systematic review of non-surgical treatments for early Dupuytren’s disease
di: Ball, C, et al.
Pubblicazione: (2015)

Effect of age at onset and parental disease status on sibling risks for MS.
di: Sadovnick, A, et al.
Pubblicazione: (1998)

Radiation therapy for early Dupuytren's disease: Interventional procedures guidance [IPG573]
di: National Institute for Health and Care Excellence, CA, et al.
Pubblicazione: (2016)

What do we know about managing Dupuytren’s Disease cost-effectively?
di: Dritsaki, M, et al.
Pubblicazione: (2018)

Dupuytren's contracture and occupational exposure to hand-transmitted vibration
di: Palmer, K, et al.
Pubblicazione: (2014)

Dupuytren's contracture and occupational exposure to hand-transmitted vibration.
di: Palmer, K, et al.
Pubblicazione: (2014)

Economic evaluation plan of a randomised controlled trial of intra-nodular injection of anti-TNF and placebo among patients with early Dupuytren’s disease: Repurposing Anti-TNF for Treating Dupuytren’s Disease (RIDD)
di: Png, M, et al.
Pubblicazione: (2019)

Recovery, responsiveness and interpretability of patient-reported outcome measures after surgery for Dupuytren's disease
di: Rodrigues, J, et al.
Pubblicazione: (2017)

Sibling chair
di: Fereday, George, et al.
Pubblicazione: (2024)

Knockout siblings
di: The Sun,
Pubblicazione: (2014)

"Saviour siblings".
di: Spriggs, M, et al.
Pubblicazione: (2002)